Diagnosing some disorders in children present unique challenges. Now, companies are looking at using artificial intelligence to uncover subtle tools to help. We also look at a new report on diversity in the biotech industry, research into long COVID-19, and Food and Drug Administration site inspections. ... READ MORE >
Health care
5 things to know in life sciences: Week of June 6, 2022
Management of diabetes care has improved dramatically since the introduction of insulin pumps and continuous glucose monitoring. Now, companies are hopeful that an “artificial pancreas” is on the horizon, which would substantially improve the standard of care for this common disease. We also look at 3D ... READ MORE >
5 things to know in life sciences: Week of May 23, 2022
This week we highlight an international collaboration for an innovative under-the-skin insulin delivery device, a focus on improving diversity for clinical trials and a promising COVID-19 vaccine for children under 5. Finally, at-home testing for sexually transmitted diseases is coming, and the University ... READ MORE >
5 things to know in life sciences: Week of May 16, 2022
This week we highlight new demand for smallpox vaccines driven by a monkeypox outbreak, the continuing need to improve representation in clinical trials, controlling machines with just your mind, and the lack of combination trials involving a COVID-19 antiviral. Finally, we look at new “smart” contacts ... READ MORE >
5 things to know in life sciences: Week of May 9, 2022
This week we highlight a promising application that leverages artificial intelligence to scan biopsies to help guide cancer treatments. We also look at a novel approach using music to treat multiple sclerosis, a new report that indicates new COVID-19 strains are starting to show a predictable pattern, and ... READ MORE >
5 things to know in life sciences: Week of May 2, 2022
This week we highlight a series of moves by the Food and Drug Administration related to COVID-19 treatments, Alzheimer's and CBD. We also look at contract research organizations and a robotics manufacturing partnership in cell and gene therapy, as well as sentiment in the biotech funding space. Each week ... READ MORE >
5 things to know in life sciences: Week of April 25, 2022
This week we highlight a bold move to continue clinical trial progress, how the contract research organization industry perceives the state of biotech funding, and machine learning and the fight against long COVID-19. We also weigh COVID-19 risks and a White House event, and the Food and Drug ... READ MORE >
5 things to know in life sciences: Week of April 18, 2022
This week we highlight new guidance from the U.S. Food and Drug Administration on ensuring that clinical trials are inclusive, Biogen’s challenges with marketing its new Alzheimer’s drug, a COVID-19 breathalyzer and how a new type of T cell could allow better targeting of solid tumors. Finally, we look at ... READ MORE >
5 things to know in life sciences: Week of April 4, 2022
This week we highlight a slow start to the year for life sciences initial public offerings, Medicare’s decision on Alzheimer’s disease reimbursement, the use of machine learning and artificial intelligence in clinical trials and the rapidly growing market for virtual trials. Finally, we look at how the ... READ MORE >
5 things to know in life sciences: Week of March 28, 2022
This week we highlight a Food and Drug Administration approval for an alternative to LASIK, promising results for a less invasive brain interface device and a precision biotech who has recently raised an additional $100 million in funding. Finally, we look at additional FDA approvals for a wearable ... READ MORE >